Bristol-Myers Squibb Co. (NYSE:BMY)
Q2 2017 Earnings Call
July 27, 2017 10:30 am ET
Executives
John E. Elicker - Bristol-Myers Squibb Co.
Giovanni Caforio - Bristol-Myers Squibb Co.
Charles A. Bancroft - Bristol-Myers Squibb Co.
Thomas J. Lynch, Jr., M.D. - Bristol-Myers Squibb Co.
Murdo Gordon - Bristol-Myers Squibb Co.
Analysts
Jami Rubin - Goldman Sachs & Co. LLC
Chris Schott - JPMorgan Securities LLC
Vamil K. Divan - Credit Suisse Securities (NYSE:USA) LLC
Gregg Gilbert - Deutsche Bank Securities, Inc.
Timothy Minton Anderson - Sanford C. Bernstein & Co. LLC
Umer Raffat - Evercore Group LLC
Seamus Fernandez - Leerink Partners LLC
Andrew S. Baum - Citigroup Global Markets Ltd.
Steve Scala - Cowen & Co. LLC
David R. Risinger - Morgan Stanley & Co. LLC
Geoff Meacham - Barclays Capital, Inc.
Marc Goodman - UBS Securities LLC
Tony Butler - Guggenheim Securities LLC
Operator
Good day, and welcome to the Bristol-Myers Squibb 2017 Second Quarter Results Conference Call. Today's conference is being recorded.
At this time, I'd like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.
